Selected diesel students at 10 campuses in six states can gain work experience while in school PHOENIX, May 28, 2024 /PRNewswire/ -- Universal Technical Institute (UTI), the transportation, skilled trades and energy education division of Universal Technical Institute, Inc., today announced that Rush Enterprises has joined the early employment program at the following campuses: UTI-Austin (Texas), UTIAvondale (Ariz.), UTI-Dallas, UTI-Houston, UTI-Lisle (Ill.), UTI-Long Beach (Calif.), UTI-Miramar (Fla.), UTI ...

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a great growth stock is not easy at all. Impressive Asset Utilization Ratio Growth investors often overlook asset utilization ratio, also known as sales-to-total-assets (S/TA) ratio, but it is an important feature of a real growth stock. This metric exhibits how efficiently a firm is utilizing its assets to generate sales. In add ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens. Zacks Premium includes access to the Zacks Style Scores as well. What are the Zacks Style Scores? ...

(Mark One) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to ______ Commission File Number: 1-31923 UNIVERSAL TECHNICAL INSTITUTE, INC. (Exact name of registrant as specified in its charter) (State or other jurisd ...

Universal Technical Institute, Inc. (NYSE:UTI) Q2 2024 Earnings Conference Call May 8, 2024 4:30 PM ET Company Participants Matt Kempton - VP, Corporate Finance Jerome Grant - CEO Troy Anderson - CFO Conference Call Participants Alex Paris - Barrington Research Eric Martinuzzi - Lake Street Raj Sharma - B. Riley Steve Frankel - Colliers Mike Grondahl - Northland Securities Operator Good day, and welcome to the Universal Technical Institute Second Quarter 2024 Earnings Conference Call. All participants will ...

Exhibit 99.1 Universal Technical Institute Reports Fiscal Year 2024 Second Quarter Results Raised Fiscal 2024 Guidance for New Student Starts, Revenue and Profitability Introducing Initial Revenue and Profitability Projections for Fiscal 2025 PHOENIX, ARIZ. - May 8, 2024 - Universal Technical Institute, Inc. (NYSE: UTI), a leading workforce solutions provider of transportation, skilled trades and healthcare education programs, reported financial results for the fiscal 2024 second quarter ended March 31, 202 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to ______ Commission File Number: 1-31923 UNIVERSAL TECHNICAL INSTITUTE, INC. (Exact name of registrant as specified in its charter) (State or other jur ...

Financial Performance - The company reported first quarter revenue of $174.7 million, a 45.6% increase year-over-year, with a full quarter contribution from Concorde of $59.3 million, which increased by $44.9 million compared to the prior year [23][22][26] - Adjusted EBITDA for the first quarter was $24.5 million, reflecting measurable year-over-year growth due to improved operating leverage and cost efficiencies [35][22] - Consolidated net income for the first quarter was $10.4 million, or $0.17 per diluted share [35] Business Line Performance - The UTI division saw a 9.3% year-over-year growth, while student starts in the UTI division increased by 17.2% year-over-year [23][34] - The company launched 14 new programs last year, with strong demand resulting in almost 400 combined student starts across these programs over the last two quarters [18][21] - Concorde's core starts grew by 14.4% on a pro forma basis, with total starts growing by 12.5% [61] Market Performance - The company anticipates generating annual revenue between $710 million and $720 million, with adjusted EBITDA expected to be between $100 million and $103 million [21][65] - The company expects to maintain a strong demand for its healthcare programs, particularly in dental hygiene, which has shown rapid enrollment growth [29][46] Company Strategy and Industry Competition - The company is focused on growth and diversification, with plans to optimize cost structures and drive increased yield from past investments [68][66] - The company is actively managing its revolver draw to minimize interest expenses while maintaining a target of approximately $30 million in capital expenditures for the year [2][8] - The company is exploring additional program expansions and potential M&A opportunities, particularly in the healthcare sector [112][91] Management Commentary on Operating Environment and Future Outlook - Management expressed confidence in the trajectory of student starts and raised full-year revenue and profitability guidance for fiscal 2024 [32][38] - The company noted that the majority of cash flow is generated in the fourth quarter, with expectations for strong unadjusted free cash flow for the fiscal year [8][38] - Management highlighted the importance of maintaining strong relationships with industry partners to enhance student employment outcomes [110] Other Important Information - The company successfully converted its Series A preferred stock into common stock, increasing total common shares outstanding by 19.3 million shares [36] - Total available liquidity at the end of the quarter was $143.6 million, including a $90 million drawdown of the revolving credit facility [64] Q&A Session Summary Question: What is working on the marketing side? - The company has significantly increased its presence in high schools, with representatives conducting multiple career presentations weekly, generating strong interest [69] Question: How is the integration of Concorde progressing? - The integration is moving into more operational aspects, including payroll and benefits, with a focus on optimizing financial systems [127] Question: What are the expectations for revenue and EBITDA growth? - The company expects strong growth in the first half of the year, with a moderation in the second half, but remains confident in achieving its full-year guidance [125][66] Question: What is the current status of the composite score? - The company is comfortably above the 1.5 threshold for the composite score, which is crucial for compliance with the Department of Education [118] Question: What are the priorities for capital allocation? - The company prioritizes growth initiatives and program expansions, while also considering M&A opportunities in the healthcare sector [86][112]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to ______ Commission File Number 1-31923 UNIVERSAL TECHNICAL INSTITUTE, INC. (Exact name of registrant as specified in its charter) (State or other jurisdictio ...

Financial Data and Key Metrics Changes - For fiscal year 2023, the company reported revenue of $607.4 million, exceeding the high-end of guidance, and adjusted EBITDA of $64.2 million, also above expectations [11][36] - Consolidated revenue for Q4 increased by 53.9% to $170.3 million, driven by a $55 million contribution from Concorde and a 4.2% year-over-year growth for the UTI division [36] - Consolidated net income for Q4 was $6.7 million, or $0.10 per diluted share, while for the full year, it was $12.3 million, or $0.13 per diluted share [37] Business Line Data and Key Metrics Changes - The UTI division contributed $429.3 million in revenue with a 2.5% year-over-year growth, while Concorde contributed $178.1 million for the 10 months post-acquisition [36] - UTI experienced a 9% growth in new student starts in Q4, with a total of 22,613 new student starts for the year [11][34] - Concorde launched three new programs in November 2023, including Diagnostic Medical Sonography and Cardiovascular Sonography [15] Market Data and Key Metrics Changes - The company reported strong demand for Concorde's programs, with new student starts in a Cardiovascular Sonography program in Florida and an online Respiratory Therapy program [22] - The Austin and Miramar campuses, launched in 2022, now have nearly 1,100 students combined, indicating a positive trajectory [18] Company Strategy and Development Direction - The company is focused on a multi-year growth and diversification strategy, including expanding into healthcare through the acquisition of Concorde [13][55] - Key focus areas for 2024 include ramping up new campuses, driving enrollment growth, and optimizing marketing and admissions investments [29][51] - The company aims to achieve adjusted EBITDA margins approaching double digits for Concorde in fiscal 2024 [46] Management's Comments on Operating Environment and Future Outlook - Management indicated that while there are no significant macroeconomic tailwinds, they are not facing strong headwinds either, suggesting a stable operating environment [66] - The company expects revenue for fiscal 2024 to be between $705 million and $715 million, representing a growth rate of 16% to 18% year-over-year [43] - Management expressed confidence in achieving fiscal 2024 guidance, which would more than double revenue from fiscal 2021 [55] Other Important Information - Total available liquidity at the end of the quarter was $159.7 million, with total debt approximately $162 million [39] - The company plans to replace adjusted net income with GAAP net income as a guidance metric for fiscal 2024 [47] Q&A Session Summary Question: What are the growth drivers for 2024? - Management identified four key drivers: full year of Concorde, program expansions, UTI organic growth, and Concorde organic growth [63][64] Question: How does the macro environment affect the company? - Management noted that while the macro environment is not providing significant tailwinds, they are not experiencing strong headwinds either, indicating a stable growth outlook [66] Question: What is the expected performance of high school versus young adult student starts? - Management expects continued strong performance in high school starts, supported by investments made in that area [77] Question: What is the status of the 90/10 rule and gainful employment updates? - The company is in the high 60% range for the 90/10 rule and does not foresee any material risk from gainful employment updates [80][81] Question: How is inflation impacting the company? - Management indicated that inflationary pressures are subsiding, and they are not experiencing significant staffing issues [93][100] Question: What is the status of the Series A preferred stock conversion? - Management expressed optimism about achieving the conversion trigger based on recent trading momentum [96]